As of April 2024 Innoviva has a market cap of $0.94 Billion. This makes Innoviva the world's 5139th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.94 B | -8.05% |
2023 | $1.02 B | 11.17% |
2022 | $0.92 B | -22.87% |
2021 | $1.19 B | -4.58% |
2020 | $1.25 B | -12.41% |
2019 | $1.43 B | -18.7% |
2018 | $1.76 B | 22.01% |
2017 | $1.44 B | 24.62% |
2016 | $1.16 B | -4.1% |
2015 | $1.20 B | -26.48% |
2014 | $1.64 B | -58.61% |
2013 | $3.97 B | 65.85% |
2012 | $2.39 B | 14.74% |
2011 | $2.08 B | 3.71% |
2010 | $2.01 B | 139.95% |
2009 | $0.83 B | 28.87% |
2008 | $0.65 B | -45.31% |
2007 | $1.19 B | -35.89% |
2006 | $1.85 B | 85.5% |
2005 | $1.00 B | 5.73% |
2004 | $0.94 B |
On Apr 19th, 2024 the market cap of Innoviva was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.85 B | -9.30% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.9 M | -97.79% | ๐บ๐ธ USA |